A model for hepatic fibrosis: the competing effects of cell loss and iron on shortened modified Look-Locker inversion recovery T1 (shMOLLI-T1) in the liver

Journal of Magnetic Resonance Imaging

Volumn 45, Issue 2, 2017, Pages 450-462

  Tunnicliffe, Elizabeth M ^a   Banerjee, Rajarshi ^a   Pavlides, Michael ^a,b   Neubauer, Stefan ^a   Robson, Matthew D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

liver disease; liver MRI; T1 mapping

Indexed keywords

IRON;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BIOLOGICAL MODEL; CELL LOSS; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE ASSESSMENT; EXTRACELLULAR FLUID; FEMALE; HEPATIC IRON CONTENT; HEPATITIS; HUMAN; INTERMETHOD COMPARISON; ISHAK SCORE; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SHORTENED MODIFIED LOOK LOCKER INVERSION RECOVERY T1; SIMULATION; APOPTOSIS; COMPUTER ASSISTED DIAGNOSIS; COMPUTER SIMULATION; DIAGNOSTIC IMAGING; LIVER CIRRHOSIS; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; APOPTOSIS; COMPUTER SIMULATION; HEPATOCYTES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 85008931485     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.25392     Document Type: Article

References (51)

1. St Pierre TG, Clark PR, Chua-anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005;105:855–861.
2. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005;106:1460–1465.
3. Thomsen C, Christoffersen P, Henriksen O, Juhl E. Prolonged T1 in patients with liver cirrhosis: An in vivo MRI study. Magn Reson Imaging 1990;8:599–604.
4. Keevil SF, Alstead EM, Dolke G, Brooks AP, Armstrong P, Farthing MJ. Non-invasive assessment of diffuse liver disease by in vivo measurement of proton nuclear magnetic resonance relaxation times at 0.08 T. Br J Radiol 1994;67:1083–1087.
5. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52:141–146.
6. Chow K, Flewitt JA, Green JD, Pagano JJ, Friedrich MG, Thompson RB. Saturation recovery single-shot acquisition (SASHA) for myocardial T1 mapping. Magn Reson Med 2014;71:2082–2095.
7. Cassinotto C, Feldis M, Vergniol J, et al. MR relaxometry in chronic liver diseases: Comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity. Eur J Radiol 2015;84:1459–1465.
8. Heye T, Yang SR, Bock M, et al. MR relaxometry of the liver: Significant elevation of T1 relaxation time in patients with liver cirrhosis. Eur Radiol 2012;22:1224–1232.
9. Kim KA, Park MS, Kim IS, et al. Quantitative evaluation of liver cirrhosis using T1 relaxation time with 3 Tesla MRI before and after oxygen inhalation. J Magn Reson Imaging 2012;36:405–410.
10. Wood JC, Otto-Duessel M, Aguilar M, et al. Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy. Circulation 2005;112:535–543.
11. Hoad CL, Palaniyappan N, Kaye P, et al. A study of T1 relaxation time as a measure of liver fibrosis and the influence of confounding histological factors. NMR Biomed 2015;28:706–714.
12. Henninger B, Kremser C, Rauch S, et al. Evaluation of MR imaging with T1 and T2* mapping for the determination of hepatic iron overload. Eur Radiol 2012;22:2478–2486.
13. Banerjee R, Pavlides M, Tunnicliffe EM, et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol 2014;60:69–77.
14. Pavlides M, Banerjee R, Sellwood J, et al. Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol 2016;64:308–315.
15. Henkelman RM, Huang X, Xiang QS, Stanisz GJ, Swanson SD, Bronskill MJ. Quantitative interpretation of magnetization transfer. Magn Reson Med 1993;29:759–766.
16. Schwen LO, Schenk A, Kreutz C, et al. Representative sinusoids for hepatic four-scale pharmacokinetics simulations. PLoS One 2015;10:e0133653.
17. Gonzalez F, Bassingthwaighte JB. Heterogeneities in regional volumes of distribution and flows in rabbit heart. Am J Physiol 1990;258:H1012–H1024.
18. Greenway CV, Stark RD. Hepatic vascular bed. Physiol Rev 1971;51:23–65.
19. Stanisz GJ, Odrobina EE, Pun J, et al. T1, T2 relaxation and magnetization transfer in tissue at 3 T. Magn Reson Med 2005;54:507–512.
20. Ghugre NR. Calibration of iron-mediated MRI relaxation by Monte Carlo modeling. PhD thesis, University of Southern California, 2008.
21. Rohrer M, Bauer HP, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005;40:715–724.
22. Ghugre NR, Wood JC. Relaxivity-iron calibration in hepatic iron overload: Probing underlying biophysical mechanisms using a Monte Carlo model. Magn Reson Med 2011;65:837–847.
23. Zimmerman JR, Brittin WE. Nuclear magnetic resonance studies in multiple phase systems: Lifetime of a water molecule in an adsorbing phase on silica gel. J Phys Chem 1957;61:1328–1333.
24. Ghugre NR, Coates TD, Nelson MD, Wood JC. Mechanisms of tissue-iron relaxivity: Nuclear magnetic resonance studies of human liver biopsy specimens. Magn Reson Med 2005;54:1185–1193.
25. Chang Y, Kim YS, Lee SK, et al. MR study of water exchange and cell membrane permeability in rat liver cells using a tissue-specific MR contrast agent. J Korean Soc Magn Reson Med 1998;2:73–82.
26. Mandeville JB, Moore J, Chesler DA, Garrido L, Weissleder R, Weisskoff RM. Dynamic liver imaging with iron oxide agents: Effects of size and biodistribution on contrast. Magn Reson Med 1997;37:885–890.
27. Blouin A, Bolender RP, Weibel ER. Distribution of organelles and membranes between hepatocytes and nonhepatocytes in the rat liver parenchyma. A stereological study. J Cell Biol 1977;72:441–455.
28. McConnell HM. Reaction rates by nuclear magnetic resonance. J Chem Phys 1958;28:430–431.
29. Piechnik SK, Ferreira VM, Dall'Armellina E, et al. Shortened modified Look-Locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010;12:69.
30. Deugnier Y, Turlin B. Pathology of hepatic iron overload. World J Gastroenterol 2007;21:4755–4760.
31. Vymazal J, Brooks RA, Zak O, Mcrill C, Shen C, Chiro GD. T1 and T2 of ferritin at different field strengths: effect on MRI. Magn Reson Med 1992;27:368–374.
32. Versluis MJ, Webb AG, van Buchem MA. Detection of cerebral microbleeds: Physical principles, technical aspects and new developments. In: Werring DJ, editor. Cerebral microbleeds: Pathophysiology to clinical practice. Cambridge, UK: Cambridge University Press; 2011. p 13–21.
33. Vymazal J, Brooks RA, Baumgarner C, et al. The relation between brain iron and NMR relaxation times: An in vitro study. Magn Reson Med 1996;35:56–61.
34. Robson MD, Piechnik SK, Tunnicliffe EM, Neubauer S. T1 measurements in the human myocardium: The effects of magnetization transfer on the SASHA and MOLLI sequences. Magn Reson Med 2013;70:664–670.
35. Bacic G, Alameda JC Jr, Iannone A, Magin R, Swartz H. NMR study of water exchange across the hepatocyte membrane. Magn Reson Imaging 1989;7:411–416.
36. Strijkers GJ, Hak S, Kok MB, Springer J Charles S, Nicolay K. Three-compartment T1 relaxation model for intracellular paramagnetic contrast agents. Magn Reson Med 2009;61:1049–1058.
37. Granger DN. Capillary exchange. In: Johnson LR, editor. Essential medical physiology, Chap. 16, 3rd ed. San Diego, CA: Academic Press; 2003. p 238.
38. Li X, Rooney WD, Springer CS. A unified magnetic resonance imaging pharmacokinetic theory: Intravascular and extracellular contrast reagents. Magn Reson Med 2005;54:1351–1359.
39. Springer CS, Li X, Tudorica LA, et al. Intratumor mapping of intracellular water lifetime: Metabolic images of breast cancer? NMR Biomed 2014;27:760–773.
40. Younossi ZM, Gramlich T, Bacon BR, et al. Hepatic iron and nonalcoholic fatty liver disease. Hepatology 1999;30:847–850.
41. Piperno A, D'Alba R, Fargion S, et al. Liver iron concentration in chronic viral hepatitis: a study of 98 patients. Eur J Gastroenterol Hepatol 1995;7:1203–1208.
42. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696–699.
43. Rial B, Robson MD, Neubauer S, Schneider JE. Rapid quantification of myocardial lipid content in humans using single breath-hold 1H MRS at 3 Tesla. Magn Reson Med 2011;66:619–624.
44. Nuttall KL, Palaty J, Lockitch G. Reference limits for copper and iron in liver biopsies. Ann Clin Lab Sci 2003;33:443–450.
45. Storey P, Thompson AA, Carqueville CL, Wood JC, de Freitas RA, Rigsby CK. R2* imaging of transfusional iron burden at 3T and comparison with 1.5T. J Magn Reson Imaging 2007;25:540–547.
46. Tang H, Jensen JH, Sammet CL, et al. MR characterization of hepatic storage iron in transfusional iron overload. J Magn Reson Imaging 2014;39:307–316.
47. He T, Gatehouse PD, Kirk P, et al. Black-blood T2* technique for myocardial iron measurement in thalassemia. J Magn Reson Imaging 2007;25:1205–1209.
48. Kellman P, Hansen MS. T1-mapping in the heart: Accuracy and precision. J Cardiovasc Magn Reson 2014;16:2.
49. Ma X, Gullberg GT, Parker DL. Magnetic resonance imaging verification of a multi-compartment perfusion model for a chromatography gel phantom. Magn Reson Imaging 1995;13:581–598.
50. Sukerkar PA, Rezvi UG, MacRenaris KW, Patel PC, Wood JC, Meade TJ. Polystyrene microsphere-ferritin conjugates: A robust phantom for correlation of relaxivity and size distribution. Magn Reson Med 2011;65:522–530.
51. Bandula S, Punwani S, Rosenberg WM, et al. Equilibrium contrast-enhanced CT imaging to evaluate hepatic fibrosis: Initial validation by comparison with histopathologic sampling. Radiology 2015;275:136–143.